NS
Article DetailSEC EDGAR Filings
首页文档检索台
SEC EDGAR Filings

8-K - Prelude Therapeutics Inc - 7.01 / 8.01 / 9.01

Filed: 2026-04-20 AccNo: 0001193125-26-162620 Size: 4 MB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
查看原文来源主页查看事件簇按来源查看
发布时间04/20 10:16 UTC
首次发现04/20 10:18 UTC
热度105.3
重要度64
情绪0.00

站内整理正文

优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 724 字符

Form 8-K - Current report: SEC Accession No. 0001193125-26-162620

Filing Date: 2026-04-20

Accepted: 2026-04-20 06:16:38

Documents: 41

Period of Report: 2026-04-20

Items: Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Prelude Therapeutics Inc (Filer) CIK : 0001678660 (see all company filings) EIN. : 811384762 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-39527 | Film No.: 26873290 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)

1 | 8-K | d135229d8k.htm iXBRL | 8-K

2 | EX-99.1 | d135229dex991.htm | EX-99.1

3 | EX-99.2 | d135229dex992.htm | EX-99.2

7 | GRAPHIC | g135229ex99_2s10g1.jpg | GRAPHIC